Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab

por El-ghazzi, Nathan, Durando, Xavier, Giro, Alexia, Herrmann, Tressie
Publicado 2023

Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study

por Herrmann, Tressie, Ginzac, Angeline, Molnar, Ioana, Bailly, Sébastien, Durando, Xavier, Mahammedi, Hakim
Publicado 2021